Lataa...
Nedaplatin: a cisplatin derivative in cancer chemotherapy
Nedaplatin, a cisplatin analog, has been developed to decrease the toxicities induced by cisplatin, such as nephrotoxicity and gastrointestinal toxicity. The dose of nedaplatin is determined by body surface area, not by the area under the curve (AUC). The recommended therapeutic dose is 80–100 mg/m(...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3658440/ https://ncbi.nlm.nih.gov/pubmed/23696716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S35785 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|